AAM
Azzad Asset Management’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-5,438
| Closed | -$1.45M | – | 320 |
|
2022
Q3 | $1.45M | Sell |
5,438
-9
| -0.2% | -$2.41K | 0.15% | 207 |
|
2022
Q2 | $1.44M | Buy |
+5,447
| New | +$1.44M | 0.14% | 213 |
|
2021
Q2 | – | Sell |
-6,411
| Closed | -$1.79M | – | 325 |
|
2021
Q1 | $1.79M | Buy |
6,411
+216
| +3% | +$60.4K | 0.3% | 141 |
|
2020
Q4 | $1.52M | Sell |
6,195
-40
| -0.6% | -$9.79K | 0.28% | 146 |
|
2020
Q3 | $1.77M | Buy |
6,235
+997
| +19% | +$283K | 0.37% | 103 |
|
2020
Q2 | $1.4M | Buy |
5,238
+2,402
| +85% | +$643K | 0.33% | 113 |
|
2020
Q1 | $897K | Sell |
2,836
-5,179
| -65% | -$1.64M | 0.26% | 142 |
|
2019
Q4 | $2.23M | Buy |
8,015
+42
| +0.5% | +$11.7K | 0.26% | 138 |
|
2019
Q3 | $2.04M | Buy |
7,973
+5,258
| +194% | +$1.34M | 0.25% | 144 |
|
2019
Q2 | $635K | Buy |
2,715
+1,117
| +70% | +$261K | 0.17% | 203 |
|
2019
Q1 | $378K | Sell |
1,598
-22
| -1% | -$5.2K | 0.11% | 247 |
|
2018
Q4 | $488K | Sell |
1,620
-118
| -7% | -$35.5K | 0.16% | 214 |
|
2018
Q3 | $614K | Sell |
1,738
-17
| -1% | -$6.01K | 0.16% | 212 |
|
2018
Q2 | $509K | Buy |
1,755
+35
| +2% | +$10.2K | 0.15% | 231 |
|
2018
Q1 | $471K | Buy |
1,720
+47
| +3% | +$12.9K | 0.14% | 231 |
|
2017
Q4 | $533K | Buy |
1,673
+79
| +5% | +$25.2K | 0.17% | 191 |
|
2017
Q3 | $499K | Buy |
1,594
+94
| +6% | +$29.4K | 0.17% | 200 |
|
2017
Q2 | $407K | Buy |
1,500
+132
| +10% | +$35.8K | 0.15% | 221 |
|
2017
Q1 | $374K | Buy |
1,368
+127
| +10% | +$34.7K | 0.14% | 217 |
|
2016
Q4 | $352K | Buy |
1,241
+44
| +4% | +$12.5K | 0.15% | 209 |
|
2016
Q3 | $375K | Sell |
1,197
-19
| -2% | -$5.95K | 0.15% | 207 |
|
2016
Q2 | $294K | Buy |
1,216
+420
| +53% | +$102K | 0.13% | 222 |
|
2016
Q1 | $207K | Buy |
796
+116
| +17% | +$30.2K | 0.09% | 230 |
|
2015
Q4 | $208K | Buy |
+680
| New | +$208K | 0.1% | 229 |
|